Denosumab is an antiresorptive drug targeting RANK ligand. currently licensed for postmenopausal and male osteoporosis. bone loss associated with hormone ablation in men with prostate cancer and with systemic glucocorticoid treatment. and also used in oncology for the treatment of bone metastases and unresectable giant cell tumour of bone. https://www.hindigyanvishv.com/hot-find-Facia-Installation-Kit-Suits-Holden-Commodore-VE-Series-2-FP9550BK-Black-top-mega/